Sorafenib in patients with progressed and refractory bone tumors
about
Sorafenib in patients with progressed and refractory bone tumors
description
im August 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 16 August 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2018
@uk
name
Sorafenib in patients with progressed and refractory bone tumors
@en
Sorafenib in patients with progressed and refractory bone tumors
@nl
type
label
Sorafenib in patients with progressed and refractory bone tumors
@en
Sorafenib in patients with progressed and refractory bone tumors
@nl
prefLabel
Sorafenib in patients with progressed and refractory bone tumors
@en
Sorafenib in patients with progressed and refractory bone tumors
@nl
P2860
P1433
P1476
Sorafenib in patients with progressed and refractory bone tumors
@en
P2093
Katarzyna Bilska
P2860
P2888
P356
10.1007/S12032-018-1180-X
P407
P577
2018-08-16T00:00:00Z